Tag: roadmap

Pepe Dollar ($PEPD) gains momentum as a best crypto presale while PEPETO nears fundraising completion during expanding Q3 2026 altcoin activity

Learn how MemeToro uses AI agents, memecoin analytics, DeFi trading, and prediction markets to help beginners discover the best crypto presale opportunities early

LUXEMBOURG, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift (BTC3), a decentralized financial operating system integrating AI automation, zk-privacy, and programmable incentives, has announced key progress in its ongoing presale. Now in Stage 5, the project has raised more than $750,000 from over 2,600 participants, with just days remaining before Stage 5 concludes and the September 18, 2025 presale deadline approaches.

LUXEMBOURG, Aug. 16, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift (BTC3), a blockchain project integrating artificial intelligence (AI) automation, decentralized identity (DID) technology, and a Proof-of-Yield (PoY) programmable rewards system, has announced that its presale is entering the final three days of Stage 5. The project has reported participation from more than 2,600 users, over $750,000 worth of BTC3 tokens sold, and more than $60,000 in staking rewards already distributed to participants.

NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The price of Ethereum (ETH) has shown notable strength over the past 24 hours, trading in the range of $4,619.49 to $4,788.55 (source: CoinMarketCap, August 15, 2025). Against this positive market backdrop, MAGACOIN FINANCE, an Ethereum-based blockchain project, has confirmed the successful close of its $12 million strategic funding round, supported by more than 10,000 verified participants — including a substantial group of early presale contributors.

BOSTON, MASSACHUSETTS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a pioneering clinical stage biotechnology company at the forefront of oxygen therapeutics, is proud to announce a major scientific milestone: the publication of Body Oxygen Homeostasis and Mitochondrial Function from Animal Models to Clinical Applications by Prof. Avraham Mayevsky, a key advisor to Bioxytran. This groundbreaking work dives deep into the science of oxygen regulation and mitochondrial health – revealing transformative insights that could redefine treatment for stroke, Alzheimer’s, and other critical conditions.

https://link.springer.com/book/10.1007/978-3-031-94113-9

CINCINNATI, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today reported financial results for the second quarter ended June 30, 2025.

Joins Workhorse’s proven vehicles, manufacturing capabilities and national dealer network with Motiv’s diverse product portfolio and top fleet relationships